oxiracetam has been researched along with Reperfusion Injury in 2 studies
oxiracetam: structure in first source
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the therapeutic effects of combined bone marrow stromal cells (BMSCs) and oxiracetam treatments on acute cerebral ischemia/reperfusion (I/R) injury." | 7.91 | Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6. ( Li, Z; Pan, Y; Sun, R; Wang, J, 2019) |
| "In this study, we use the middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen glucose deprivation/reoxygenation (OGD/R) model in fetal rat primary cortical neurons to investigate whether and how S-oxiracetam (S-ORC) protect brain injury from ischemic stroke." | 5.48 | S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats. ( Fan, W; Fang, W; Fu, Y; He, S; Huang, L; Li, X; Li, Y; Xie, Z, 2018) |
| " In this study, we investigated the therapeutic effects of combined bone marrow stromal cells (BMSCs) and oxiracetam treatments on acute cerebral ischemia/reperfusion (I/R) injury." | 3.91 | Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6. ( Li, Z; Pan, Y; Sun, R; Wang, J, 2019) |
| "In this study, we use the middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen glucose deprivation/reoxygenation (OGD/R) model in fetal rat primary cortical neurons to investigate whether and how S-oxiracetam (S-ORC) protect brain injury from ischemic stroke." | 1.48 | S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats. ( Fan, W; Fang, W; Fu, Y; He, S; Huang, L; Li, X; Li, Y; Xie, Z, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, W | 1 |
| Li, X | 1 |
| Huang, L | 1 |
| He, S | 1 |
| Xie, Z | 1 |
| Fu, Y | 1 |
| Fang, W | 1 |
| Li, Y | 1 |
| Wang, J | 1 |
| Sun, R | 1 |
| Li, Z | 1 |
| Pan, Y | 1 |
2 other studies available for oxiracetam and Reperfusion Injury
| Article | Year |
|---|---|
S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3β signal pathway in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Survival; Infarction, Middle Cerebral Artery; Male; Neurons | 2018 |
Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6.
Topics: Animals; Bone Marrow Transplantation; Brain Ischemia; Calpain; Cerebral Cortex; Cyclic AMP Response | 2019 |